Federated Hermes
IPSC icon

Federated Hermes’s Century Therapeutics IPSC Stock Holding History

Federated Hermes’s Portfolio IPSC Stock Details IPSC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-276,163
Closed -$704K – 2110
2024
Q2 		$704K Sell
276,163
-338,980
-55% -$1.07M ﹤0.01% 1218
2024
Q1 		$2.57M Sell
615,143
-3,339
-0.5% -$14.1K 0.01% 871
2023
Q4 		$2.05M Buy
618,482
+2,500
+0.4% +$4.55K 0.01% 944
2023
Q3 		$1.23M Buy
615,982
+1,888
+0.3% +$5.02K ﹤0.01% 1049
2023
Q2 		$1.94M Sell
614,094
-550,517
-47% -$1.77M ﹤0.01% 959
2023
Q1 		$4.04M Buy
1,164,611
+158
+0% +$694 0.01% 754
2022
Q4 		$5.97M Buy
1,164,453
+359
+0% +$3.39K 0.02% 647
2022
Q3 		$11.5M Hold
1,164,094
– – 0.03% 497
2022
Q2 		$9.78M Hold
1,164,094
– – 0.03% 549
2022
Q1 		$14.7M Hold
1,164,094
– – 0.03% 519
2021
Q4 		$18.5M Hold
1,164,094
– – 0.03% 509
2021
Q3 		$29.3M Buy
1,164,094
+614,094
+112% +$16.6M 0.06% 395
2021
Q2 		$16.1M Buy
+550,000
New +$14M 0.03% 530

Other funds holding IPSC

BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Federated Hermes's IPSC Position: Q3 2024 in Review

Federated Hermes sold out of Century Therapeutics (IPSC) in Q3 2024, closing a stake of 276,163 shares — an estimated $704K sold.

Federated Hermes first reported a position in IPSC in Q2 2021 and held it in 13 quarters. The position peaked at $29.3M in Q3 2021. 67 funds tracked by Wall St. Rank hold IPSC as of Q3 2024.

  • Federated Hermes reported no remaining Century Therapeutics position as of Q3 2024 after selling out during the quarter.
  • Federated Hermes sold 276,163 Century Therapeutics shares in Q3 2024, an estimated $704K.
  • Federated Hermes first reported a position in Century Therapeutics in Q2 2021 and held it in 13 quarters.
  • Federated Hermes's Century Therapeutics position peaked at $29.3M in Q3 2021.
  • 67 funds tracked by Wall St. Rank held Century Therapeutics as of Q3 2024.

Based on Federated Hermes's 13F filing for Q3 2024, filed 13 Nov 2024.